Evaluating Neutralizing Antibodies in Hantavirus-Infected Patients Using Authentic Virus and Recombinant Vesicular Stomatitis Virus Systems
Hantaviruses, including the Sin Nombre virus (SNV) and Andes virus (ANDV), are associated with severe global health risks, causing high mortality rates in hantavirus pulmonary syndrome (HPS) patients. Neutralizing antibodies are essential for virus clearance and survival, making neutralization assay...
Saved in:
| Main Authors: | Punya Shrivastava-Ranjan, Jamie A. Kelly, Laura K. McMullan, Deborah Cannon, Laura Morgan, Payel Chatterjee, Shilpi Jain, Joel M. Montgomery, Mike Flint, César G. Albariño, Christina F. Spiropoulou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/17/5/723 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preclinical evaluation of a fully human, quadrivalent-hantavirus polyclonal antibody derived from a non-human source
by: Rebecca L. Brocato, et al.
Published: (2024-10-01) -
Sin Nombre Virus as Unlikely Reverse Zoonotic Threat
by: Jérémie Prévost, et al.
Published: (2025-02-01) -
Vaccines for Prevention of Hantaviral Fevers
by: A. A. Sinyugina, et al.
Published: (2019-11-01) -
Oncolytic Vesicular Stomatitis Virus: Optimisation Strategies for Anti-Cancer Therapies
by: Margarita Zinovieva, et al.
Published: (2024-10-01) -
High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission
by: Igor Morozov, et al.
Published: (2021-01-01)